Key Takeaways:
- CVS Health (CVS, Financial) impresses with a first-quarter Non-GAAP EPS of $2.25, topping expectations by $0.58.
- Revenues hit $94.6 billion, beating estimates by $1.23 billion, leading to a revised 2025 financial outlook.
- Potential 12.19% upside suggested by analyst average price target, with a substantial 31.6% upside indicated by GuruFocus' GF Value estimate.
Strong Financial Performance in Q1
CVS Health (CVS) has delivered a robust first-quarter performance marked by a Non-GAAP EPS of $2.25, outpacing analysts' estimates by $0.58. This strong earnings performance is complemented by revenues surging to $94.6 billion, surpassing forecasts by $1.23 billion. In response to this solid performance, CVS Health has boosted its 2025 guidance, increasing both adjusted EPS and expected cash flow from operations, signaling confidence in its future financial trajectory.
Wall Street Analysts' Insights on CVS
Wall Street analysts are optimistic about CVS Health Corp (CVS, Financial), with 24 analysts providing a one-year average price target of $74.84. This averages to a potential upside of 12.19% from the current trading price of $66.71. The high estimate reaches $90.00, while the low sits at $60.00. For a detailed overview of these predictions, visit the CVS Health Corp (CVS) Forecast page.
Brokerage Recommendations & GF Value Outlook
The consensus recommendation from 29 brokerage firms places CVS Health Corp (CVS, Financial) at an average rating of 2.2, indicating an "Outperform" status. This rating reflects positive sentiment among analysts, with 1 being a Strong Buy recommendation and 5 being a Sell.
According to GuruFocus, the estimated GF Value for CVS Health Corp (CVS, Financial) in a year is projected at $87.79, predicting a substantial upside of 31.6% from its current market price of $66.71. The GF Value provides a comprehensive fair value assessment, factoring in historical trading multiples, past growth, and future business forecasts. For more in-depth information, visit the CVS Health Corp (CVS) Summary page.
